Any unexpected side effect, like water retention, could be a sign of contaminants triggering an off-target reaction
Semaglutide, the active ingredient in Ozempic and Wegovy, is a modified version of human GLP-1
Prior authorization requirements are common among commercial payers for ongoing injection therapy, so verify coverage and authorization requirements with each plan before initiating therapy for private-pay patients
Executing it properly is another entirely
Evidence suggests that diabetes exacerbates the aggregation of -synuclein, a protein that accumulates in the brain in patients with PD, forming Lewy bodies
Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK